PDA

View Full Version : Palbociclib shows promise in patients with hormone-resistant breast cancer

News
02-25-2015, 02:36 AM
Targeted therapy drug recently approved by FDA for use in newly metastatic breast cancer patientsPalbociclib, an investigational oral medication that works by blocking molecules responsible for...

More... (http://www.medicalnewstoday.com/releases/289813.php)